Interview with the Director of Corporate Development and U.S. Representative: Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Healthcare >> CEO Interviews >> November 27, 2015

R. Scott Cramer is a member of the board of directors of Skystar Bio-Pharmaceutical Company, Director of Corporate Development and U.S. Representative. He has been with the company since its public inception in 2005 and has played an integral role in Skystar’s listing on Nasdaq in March 2009. Previously, Mr. Cramer served as Chairman and Chief Executive Officer of The Cyber Group Corporation, a publicly traded company, from November 2001 to November 2005 and as its Chief Financial Officer from April 2003 to November 2005. Mr. Cramer is the Founder and President of Cramer & Rauchegger, an independent financial advisory firm specializing in retirement management, estate planning and wealth management. In 2013, the firm was ranked amongst the top-three financial planning firms in central Florida by the Orlando Business Journal and listed as one of Orlando’s top wealth management firms by the National Association of Board Certified Advisory Practices, who also awarded the firm first place in the category of risk management. Mr. Cramer’s expertise and opinions have been frequently sought after by various television, print, wire and online media outlets, such as Bloomberg TV, CNBC, Fox Business, Smart Money, Dow Jones Newswire, Reuters, Bankrate.com, AOL DailyFinance and many others. Mr. Cramer has more than 30 years of experience as a financial adviser; his credentials include Chartered Retirement Planning Counselor, certified estate planning professional and a certified annuity adviser. Profile

TWST: How was Skystar formed?

Mr. Cramer: Skystar is a manufacturer of vaccines, medicines, feed additives and probiotics. Back in 2005, Skystar wanted access to the capital markets, so

Join for free to read a longer excerpt or purchase this article

Interview with the Director of Corporate Development and U.S. Representative: Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the Director of Corporate Development and U.S. Representative: Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS